Alignment Healthcare (ALHC) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
18 Jan, 2026Executive summary
Health plan membership reached 182,300 as of September 30, 2024, up 58% year-over-year, surpassing guidance and expectations, driven by expansion across 53 markets in six states.
Revenues increased 52% year-over-year to $692.4 million for Q3 2024, with revenue excluding ACO REACH up 62.4%.
Adjusted gross profit was $81 million and adjusted EBITDA was $6 million, both at the high end of guidance, with net loss improving to $26.4 million.
98% of members are in plans rated four stars or above for 2025, with one contract earning a 5-star CMS rating.
The company is positioned to benefit from CMS policy changes and expects continued Stars tailwinds through 2028.
Financial highlights
Q3 2024 revenue was $692.4 million, up 52% year-over-year, marking the highest growth quarter as a public company.
Adjusted gross profit was $80.5 million and adjusted EBITDA was $5.9 million, both improved from prior year.
Adjusted SG&A as a percentage of revenue (excluding ACO REACH) improved by 540 basis points year-over-year to 10.8%.
Ended the quarter with $381 million in cash and investments, including $105 million at the parent company.
Medical expenses increased 54.2% to $613.4 million in Q3 2024, primarily due to membership growth.
Outlook and guidance
Q4 2024 guidance: Health plan membership of 184,000–186,000, revenue of $663–$678 million, adjusted gross profit of $67–$82 million, and adjusted EBITDA between a loss of $10 million and a gain of $5 million.
Full-year 2024 guidance: Revenue of $2.67–$2.68 billion, adjusted gross profit of $282–$297 million, and adjusted EBITDA between a loss of $10 million and a gain of $5 million.
Year-end membership guidance raised by 6,000 at midpoint, now expecting 55% year-over-year growth.
2025 outlook includes at least 20% membership growth and consensus adjusted EBITDA of $40 million, with margin expansion prioritized.
Management expects continued investment in technology, market expansion, and product innovation to drive long-term growth.
Latest events from Alignment Healthcare
- Disciplined growth, robust retention, and scalable care models drive strong performance.ALHC
Leerink Global Healthcare Conference 202610 Mar 2026 - 2025 revenue rose 46% with margin gains; 2026 guidance signals strong growth and cash flow.ALHC
Q4 202527 Feb 2026 - Refinancing, tech-driven care, and stable trends support 20%+ growth and margin expansion in 2025.ALHC
Stephens 26th Annual Investment Conference | NASH20243 Feb 2026 - Q2 revenue up 47% and membership up 56%, with improved margins and raised 2024 guidance.ALHC
Q2 20242 Feb 2026 - 51% YoY growth, tech-driven care, and cost control set up 20%+ expansion in 2025.ALHC
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Strong cost control, margin focus, and California-led growth position the company for 2025 success.ALHC
Baird's 2024 Global Healthcare Conference20 Jan 2026 - Tech-driven care and disciplined growth deliver strong margins, high ratings, and rapid expansion.ALHC
44th Annual J.P. Morgan Healthcare Conference14 Jan 2026 - Margin expansion and regulatory tailwinds drive growth and operational focus through 2028.ALHC
UBS Global Healthcare Conference 202414 Jan 2026 - Technology-driven care model delivers record growth, profitability, and quality ratings.ALHC
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026